Clinical trial Recruiting at 1 site Phase 2 Interventional Ages 12 Months to 71 Months

High-dose Vitamin D to prevent asthma-like symptoms in young children

Official title: High-dose Vitamin D Supplement for the Prevention of Acute Asthma-like Symptoms in Preschool Children - a Double-blind, Randomized, Controlled Trial

Run by Copenhagen Studies on Asthma in Childhood · NCT05043116 · Data updated 2026-11-12

This study is testing if giving high doses of vitamin D can help prevent asthma-like symptoms in young children aged 1-5 who often struggle with coughing and wheezing.

More Asthma in Children trials

Quick facts

PhasePhase 2
Study typeInterventional
Ages12 Months to 71 Months
SexAll
Enrollment320 (estimated)
SponsorCopenhagen Studies on Asthma in Childhood
Academic / other
Locations1 site (Gentofte Municipality, Gentofte)
StatusRecruiting
StartedOctober 1, 2022
Main results expectedOctober 16, 2028
Study endsOctober 1, 2031
Registry record updatedApril 16, 2025
Trial IDNCT05043116 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are preschool children aged 1-5 years who have been hospitalized due to acute asthma-like symptoms.

Probably not a fit

Patients hospitalized with pneumonia or those exceeding the daily recommended intake of vitamin D will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effects of high-dose vitamin D supplementation on preventing acute asthma-like symptoms in preschool children aged 1-5 years. It focuses on children admitted to a pediatric ward due to episodes characterized by coughing, wheezing, and difficulty breathing, often triggered by respiratory infections. The intervention involves administering cholecalciferol D3 compared to a placebo to assess its efficacy in reducing the frequency of these acute episodes. The study aims to address the growing prevalence of asthma and its significant impact on young children's health and well-being.

Why it matters

Potential benefit: If successful, this could significantly reduce the frequency of asthma-like symptoms and hospital visits in preschool children.

How similar studies have gone: Other studies have shown promising results with vitamin D supplementation in respiratory conditions, but this specific approach in preschool children is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

The study population consists of children in the age group 1-5 years admitted to a pediatric ward, due to an acute episode with asthma-like symptoms. An acute asthma-like episode will be defined as annoying coughing, wheezing (wheezing or wheezing in connection with exhalation) and / or dyspnoea, which affects the child's well-being and requires hospitalization in a pediatric ward. Participation in the study requires that the child is in or has been in treatment with SABA, as monotherapy, or in combination with ICS, and possibly also in combination with LTRA in accordance with the Danish guidelines

Exclusion Criteria:

* The child is hospitalized with pneumonia
* The child's daily intake of vitamin D supplementation is\> 400 IU / day (\~ 10 μg / day).
* The child is given a combination of vitamin and dietary supplements containing vitamin D, thus the daily recommended dose is exceeded, as 2400 IU / day (\~ 60 μg / day) is accepted for children aged 1-4 years, as everyone here is recommended to take 400 IU / day (\~ 10 μg / day) by the Danish Health and Medicines Authority.
* The baby has been exclusively breastfed for the past 6 months.
* The child is malnourished

  * for children\> 2 years of age whose age-specific BMI is less than the 3rd percentile.
  * for children \<2 years, whose weight or height in relation to age is less than the 3rd percentile.
* The child is a newly arrived refugee or immigrant from regions with a high risk of rickets.
* The child has other chronic lung diseases.
* The child is diagnosed with other conditions such as chronic lung disease, impaired renal function, neurological or psychiatric disorders, congenital or documented acquired QT prolongation, clinically relevant bradycardia, cardiac arrhythmia or severe heart failure and / or hepatic impairment.
* The child is being treated with medication that alters calcium or vitamin D absorption / metabolism.

Where it's running

  • University Hospital of Copenhagen
    Gentofte Municipality, Gentofte, Denmark
    Recruiting

Study contacts

  • Principal investigator: Bo Chawes, MD, DMSc — chawes@copsac.com
  • Study coordinator: Klaus Bønnelykke, MD, PhD
  • Email: kb@copsac.com
  • Phone: +4538677360

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • N-WATCH: Can a simple breath device help monitor asthma in kids

    This study tests the N-Tidal C device to see if it helps monitor asthma in children aged 5 to under 16 who have wheeze or asthma and are not critically ill.

    Recruiting at 2 sites University of Nottingham · Nottingham, Nottinghamshire and 1 other locations · NCT07833826

  • Smart Inhaler Use at Home for Adolescents with IDD and Asthma

    This study tests whether daily use of active smart inhalers at home helps adolescents with intellectual disabilities manage asthma better.

    Recruiting Children's Hospital Los Angeles · Los Angeles, California · NCT07746921

  • ASMact: Managing bronchial asthma attacks in children

    This study tries a GINA 2025-based staff education and care-standardization approach to see if emergency treatment for children aged 6–17 with acute asthma attacks improves outcomes.

    Recruiting at 2 sites Meyer Children's Hospital IRCCS · Ferrara, FE and 1 other locations · NCT07412769

  • Biomarkers and Respiratory Omics in Children: Predicting Disease Course

    This study tests whether biomarkers from the lungs and blood can predict how asthma and protracted bacterial bronchitis in children will progress and respond to current therapies.

    Recruiting Medical University of Warsaw · Warsaw · NCT07232550

  • Using technology and school–clinic coordination to improve asthma care for children.

    This project will try a tech-enabled program plus school care coordination to help children ages 4–12 with persistent or uncontrolled asthma follow guideline-based treatment and have fewer symptoms and school problems.

    Recruiting Montefiore Medical Center · The Bronx, New York · NCT07224061

  • Boosting use of SMART inhaler therapy for children with moderate-to-severe asthma

    This project will test whether adding community health workers and nurse care managers to electronic health record decision support and education helps children ages 5–18 with uncontrolled asthma use single maintenance and reliever therapy (SMART).

    Recruiting Children's Hospital of Philadelphia · Philadelphia, Pennsylvania · NCT07138027

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.